Live Breaking News & Updates on Myotonic Dystrophy Type

Stay updated with breaking news from Myotonic dystrophy type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PepGen (PEPG) Announces FDA has Lifted the Clinical Hold on its INDA for FREEDOM-DM1 Phase 1 Study of PGN-EDODM1

PepGen (PEPG) Announces FDA has Lifted the Clinical Hold on its INDA for FREEDOM-DM1 Phase 1 Study of PGN-EDODM1
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Sarah Sutton , Laurence Watts , James Mcarthur , Drug Administration , Pepgen Inc , Gilmartin Group , Company Investigational New Drug Application , Investigational New Drug Application , Enhanced Delivery Oligonucleotide , Myotonic Dystrophy Type , Duchenne Muscular Dystrophy , Private Securities Litigation Reform Act ,